| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 7 securities · passive | ||||||
|
Relay Therapeutics, Inc.
13G/A
RLAY · 75943R102
|
9.9% |
11/16/2026
Event 9/30/2026
|
||||
| SB Investment Advisers (UK) Limited | 9.9% | |||||
| SoftBank Vision Fund (AIV M2) L.P. | 9.9% | |||||
| SVF Pauling (Cayman) Ltd | 9.9% | |||||
|
Energy Vault Holdings, Inc.
13G/A
NRGV · 29280W109
|
8.9% |
5/15/2026
Event 3/31/2026
|
||||
| SB Investment Advisers (UK) Limited | 8.9% | |||||
| SoftBank Vision Fund (AIV M2) L.P. | 8.9% | |||||
|
Vir Biotechnology, Inc.
13G/A
VIR · 92764N102
|
6.5% |
5/15/2026
Event 3/31/2026
|
||||
| SB Investment Advisers (UK) Limited | 6.5% | |||||
| SoftBank Vision Fund (AIV M1) L.P. | 6.5% | |||||
| SVF Endurance (Cayman) Limited | 6.5% | |||||
|
Roivant Sciences Ltd.
13G/A
ROIV · G76279101
|
2.3% |
2/17/2026
Event 12/31/2025
|
||||
| SB Investment Advisers (UK) Limited | 2.3% | |||||
| SoftBank Vision Fund L.P. | 2.3% | |||||
| SVF Holdings (UK) LLP | 2.3% | |||||
| SVF Investments (UK) Limited | 2.3% | |||||
|
Compass, Inc.
13G/A
COMP · 20464U100
|
4.5% |
2/17/2026
Event 12/31/2025
|
||||
| SB Investment Advisers (UK) Limited | 4.5% | |||||
| SoftBank Vision Fund (AIV M1) L.P. | 4.5% | |||||
| SVF Endurance (Cayman) Limited | 4.5% | |||||
| SVF Excalibur (Cayman) Limited | 4.5% | |||||
|
Full Truck Alliance Co. Ltd.
13G/A
YMM · 35969L108
|
7.4% |
11/14/2025
Event 9/30/2025
|
||||
| SB Investment Advisers (UK) Limited | 7.4% | |||||
| SoftBank Vision Fund L.P. | 7.4% | |||||
| SVF Holdings (UK) LLP | 7.4% | |||||
| SVF Holdings (Singapore) Pte. Ltd. | 7.4% | |||||
| SVF Truck (Singapore) Pte. Ltd. | 7.4% | |||||
|
Coupang, Inc.
13G/A
CPNG · 22266T109
|
17.3% |
11/14/2025
Event 9/30/2025
|
||||
| SB Investment Advisers (UK) Limited | 17.3% | |||||
| SVF Investments (UK) Limited | 17.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.